A Phase I/II Study of Panitumumab/Cisplatin/Fluorouracil Combined With Radiation Preoperatively for Patients With Locally Advanced Esophageal Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 16 Mar 2018
At a glance
- Drugs Panitumumab (Primary) ; Cisplatin; Fluorouracil
- Indications Oesophageal cancer
- Focus Adverse reactions
- 22 Dec 2017 Status changed from completed to discontinued.
- 16 Nov 2016 Status changed from active, no longer recruiting to completed.
- 21 Mar 2016 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016, according to ClinicalTrials.gov record.